|
Weekly Market: Grim end to Terrible Week; Markets decline 3%
|
Friday, March 13, 2015 |
| Market Commentary | | Grim end to Terrible Week; Markets decline 3% | The Indian markets wrapped up the week ended March 13, 2015 in the red zone reversing the gaining trend of last 3-week. The Sensex ended 3.21% lower, while the Nifty fell 3.24% in the week. |
Major Headlines for the week: Indian indices: Welcome to the 'Weekly Market Wrap' for Friday, March 13, 2015 where key benchmark indices edged lower in the week ended Thursday, March 13, 2015. The market logged losses in four out of the five trading sessions of the week. Markets declined on weak global cues. The sentiment was adversely hit by expectations that the US Federal Reserve may raise interest rates sooner than previously thought which would result in funds moving away from the emerging markets. Also, Greece worries bubbled to the surface again. The S&P BSE Mid-Cap index declined 250.20 points or 2.26% to settle at 10,794.88. The S&P BSE Small-Cap index slumped 247.29 points or 2.15% to settle at 11,209.56. In the week ended Friday, March 13, 2015, the 30-share S&P BSE Sensex declined 945.65 points or 3.21% to 28,503.30. The 50-unit CNX Nifty fell 290 points or 3.24% to 8647.75. Weekly market trend from March 09 - March 13: March 09: Indian shares fell 2% on Monday, heading towards their biggest single-day drop in four weeks as stronger-than-expected US jobs data raised expectation the Federal Reserve would raise interest rates sooner than previously thought. The S&P BSE Sensex and CNX Nifty ended 2.05%-2.03% lower each. March 10: India's BSE index fell for a second consecutive session on Tuesday, to mark its lowest close in nearly 3-1/2 weeks, on continued worries the U.S. Federal Reserve may hike interest rates by mid-year, dampening appetite for risky assets. The S&P BSE Sensex and CNX Nifty ended 0.47%-0.51% lower each. March 11: India's benchmark BSE index fell to a one-month closing low on Wednesday, falling for the third straight session, as metal stocks such as Hindalco Industries plunged over an investigation into the allocation of coal blocks. The S&P BSE Se nsex and CNX Nifty ended 0.18%-0.14% lower each. March 12: Indian shares rose nearly 1 percent on Thursday on hopes Prime Minister Narendra Modi would be able to steer a bill seeking to raise foreign investment limits in the insurance sector through the upper house of parliament, raising optimism about further economic reforms. The S&P BSE Sensex and CNX Nifty ended 0.95%-0.87% higher each. March 13: Indian shares fell nearly 1.5 percent on Friday, marking their biggest weekly fall this year, as lenders slumped after an increase in consumer inflation data raised concerns about interest rate cuts and sent bond yields surging. The S&P BSE Sensex and CNX Nifty ended 1.48%-1.46% lower each. Global indices: Majority of the global markets ended in green except FTSE 100 declined 2.18% and Hang Seng fell 1.41%. Topmost Gainers are: Shanghai Composite jumped 4.06%, Dax 100 rose 2.15%, Nikkei gained 1.49% and CAC 40 up 0.46%. Sectoral and stock screening: Among 13 sectors only one sector ended green S&P BSE Consumer Durables rose 1.21%. Topmost Losers: S&P BSE Capital Goods dipped 4.98%, S&P BSE Bankex slipped 4.94%, S&P BSE Oil & Gas fell 3.63% and S&P BSE Metal down 3.32%. | Looking at the 'A' group stocks, the top three gainers of the week were - Natco Pharma up 46.66%, Idea Cellular up 21.44% and Rajesh Exports up 15.22%. Top three losers of the week were - Persistent Systems down 56.92%, Adani Power down 15.67% and Tata Elxsi down 14.66% FII/MF activity: The foreign institutional investors (FIIs) have been the net sellers of the Indian stocks to the tune of Rs20.26 crore and the domestic investors bought Indian shares worth a net of Rs531.5 crore as on March 11, 2015. | TOP MOVERS (GROUP A) |  | | | | | Natco Pharma | 2,219.70 | 46.66 | | Idea Cellular | 182.10 | 21.44 | | Rajesh Exports | 191.10 | 15.22 | | | Persistent Systems | 805.95 | -56.92 | | | Tata Elxsi | 1,228.20 | -14.66 | | | | | | FII/MF ACTIVITIES |  | | | | Gross purchase | 14,545.60 | 2,735.60 | | Gross sale | 14,565.86 | 2,204.10 | | Net investment | -20.26 | 531.50 | | | | | | | | Data as on March 11, 2015 | | | Market Outlook for the coming week! In the coming week, corporate advance tax data for the fourth and final installment of 15 March, data on inflation based on the wholesale price index for February 2015, trend in global markets, investment by foreign portfolio investors (FPIs), the movement of rupee against the dollar, crude oil price movement and developments in the ongoing budget session of Parliament will dictate the near term trend on the bourses. Developments in the ongoing budget session of Parliament will be closely watched. Corporate advance tax payment for the fourth and final installment which is due by Sunday, 15 March 2015, could provide clues on Q4 March 2015 corporate earnings. Wind power solutions provider Inox Wind is hitting the capital market next week to raise up to Rs700 crore through an initial public offering (IPO) to fund expansion and meet other requirements. The issue opens on March 18, 2015 and closes on March 20, 2015. The price band has been fixed between Rs315 to Rs325 per share. A discount of Rs15 per equity share to the issue price is being offered to retail individual bidders and eligible employees in the issue. On the macro front, the government will unveil data on inflation based on the wholesale price index for February 2015 on Monday, March 16, 2015. Shares of public sector oil marketing companies (PSU OMCs) and auto firms will be in focus as a fuel price review is due. PSU OMCs review fuel prices during the middle of the month and on the last day of the month based on the average imported oil price in the preceding fortnight. Among global events, a two-day meeting of the Federal Open Market Committee (FOMC) to review US monetary policy is scheduled on 17-18 March 2015. Although no rate changes are expected this time, investors will closely be watching Federal Reserve Chairwoman Janet Yellen's press conference for any hints on how patient the central bank will be before tightening its monetary policy. | | To know more about our products and services, click here. | | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com Contact: myaccount@sharekhan.com | | | |
posted by Anonymous @ 4:31 PM  |
|
1 Comments: |
-
BLOOD BATH IN WALCHANDNAGAR LTD.!!!! CALL GIVEN@183.00. LOW-172.30, PROFIT RS.11253 IN JUST 1CALL ENJOY PROFIT JOIN OUR BEST STOCK CASH SERVICES. stock cash tips
|
|
<< Home |
|
|
|
|
BLOOD BATH IN WALCHANDNAGAR LTD.!!!! CALL GIVEN@183.00. LOW-172.30, PROFIT RS.11253 IN JUST 1CALL ENJOY PROFIT JOIN OUR BEST STOCK CASH SERVICES.
stock cash tips